The shape of things to come: Importance of design in nanotechnology for drug delivery

Therapeutic Delivery

Volumn 3, Issue 2, 2012, Pages 181-194

  Liu, Yaling ^a   Tan, Jifu ^a   Thomas, Antony ^a   Ou Yang, Daniel ^b   Muzykantov, Vladimir R ^c  

^a Lehigh University   (United States)

^b LEHIGH UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

it consists of the phagocytic cells located in reticular connective tissue; The same as mononuclear phagocyte system

Indexed keywords

NANOPARTICLE;

CELL SHAPE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG RELEASE; INTERNALIZATION; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; VIRUS MORPHOLOGY;

EID: 84863116573     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.11.156     Document Type: Review

References (106)

1. Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review. Curr. Drug Deliv. 4(4), 297-305 (2007). (Pubitemid 47554274)
2. Sharma G, Anabousi S, Ehrhardt C, Ravi Kumar MN. Liposomes as targeted drug delivery systems in the treatment of breast cancer. J. Drug Target 14(5), 301-310 (2006). (Pubitemid 44173296)
3. Sutton D, Nasongkla N, Blanco E, Gao J. Functionalized micellar systems for cancer targeted drug delivery. Pharm. Res. 24(6), 1029-1046. (2007) (Pubitemid 46798882)
4. Torchilin VP. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol. Life Sci. 61(19-20), 2549-2559 (2004). (Pubitemid 39591627)
5. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S. In vivo molecular and cellular imaging with quantum dots. Curr. Opin. Biotechnol. 16(1), 63-72 (2005). (Pubitemid 40249760)
6. Smith AM, Ruan G, Rhyner MN, Nie S. Engineering luminescent quantum dots for in vivo molecular and cellular imaging. Ann. Biomed. Eng. 34(1), 3-14 (2006).
7. Koenig S, Chechik V. Shell cross-linked Au nanoparticles. Langmuir 22(11), 5168-5173 (2006).
8. Lou X, Wang C, He L. Core-shell Au nanoparticle formation with DNA-polymer hybrid coatings using aqueous ATR. Biomacromolecules 8(5), 1385-1390 (2007). (Pubitemid 46865106)
9. Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv. Drug Deliv. Rev. 57(15), 2215-2237 (2005). (Pubitemid 41759394)
10. Najlah M, D'Emanuele A. Crossing cellular barriers using dendrimer nanotechnologies. Curr. Opin. Pharmacol. 6(5), 522-527 (2006). (Pubitemid 44340663)
11. Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128(6), 2115-2120 (2006). (Pubitemid 43277351)
12. Sardar R, Shumaker-Parry JS. Asymmetrically functionalized gold nanoparticles organized in one-dimensional chains. Nano. Lett. 8(2), 731-736 (2008). (Pubitemid 351346048)
13. Park JH, von Maltzahn G, Zhang L et al. Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small 5(6), 694-700 (2009).
14. Dai Q, Worden JG, Trullinger J, Huo Q. A 'nanonecklace' synthesized from monofunctionalized gold nanoparticles. J. Am. Chem. Soc. 127(22), 8008-8009 (2005). (Pubitemid 40799643)
15. Geng Y, Dalhaime P, Cai S et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2(4), 249-255 (2007). (Pubitemid 46739812)
16. Simone EA, Dziubla TD, Muzykantov VR. Polymeric carriers: role of geometry in drug delivery. Expert Opin. Drug Deliv. 5(12), 1283-1300 (2008).
17. Alexis F, Pridgen E, Molnar LK, Farokhzad OC. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5(4), 505-515 (2008).
18. Chen HY, Yang M, Wang X, Tan LH, Chen H. Controlled assembly of eccentrically encapsulated gold nanoparticles. J. Am. Chem. Soc. 130(36), 11858-11859 (2008).
19. Dormidontova EE, Djohari H. Kinetics of nanoparticle targeting by dissipative particle dynamics simulations. Biomacromolecules 10(11), 3089-3097 (2009).
20. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263(5153), 1600-1603 (1994). (Pubitemid 24128361)
21. Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 380(6572), 364-366 (1996). (Pubitemid 26097120)
22. Farokhzad OC, Jon S, Khademhosseini A, Tran TN, Lavan DA, Langer R. Nanoparticle-aptamer bioconjugates. Cancer Res. 64(21), 7668-7672 (2004).
23. Cheng J, Teply BA, Sherifi I et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28(5), 869-876 (2007). (Pubitemid 44667020)
24. Kubowicz S, Baussard JF, Lutz JF, Thunemann AF, von Berlepsch H, Laschewsky A. Multicompartment micelles formed by self-assembly of linear ABC triblock copolymers in aqueous medium. Angewandte Chem. Int. Ed. 44(33), 5262-5265 (2005). (Pubitemid 41223879)
25. Li G, Shi L, Ma R, An Y, Huang N. Formation of complex micelles with double-responsive channels from self-assembly of two diblock copolymers. Angewandte Chem. Int. Ed. 45(30), 4959-4962 (2006). (Pubitemid 44166129)
26. Lee ES, Oh KT, Kim D, Youn YS, Bae YH. Tumor pH-responsive flower-like micelles of poly(l-lactic acid)-b-poly(ethylene glycol)-b-poly(l-histidine). J. Control. Release 123(1), 19-26 (2007). (Pubitemid 47444389)
27. Oh KT, Kimb D, Youc HH, Ahnc YS, Lee ES. pH-sensitive properties of surface charge-switched multifunctional polymeric micelle. Int. J. Pharm. 376(1-2), 134-140 (2009).
28. Guo X, Szoka FC. Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG-diortho ester-lipid conjugate. Biocon. Chem. 12(2), 291-300 (2001). (Pubitemid 32235482)
29. Reynhout IC, Cornelissen JJ, Nolte RJM. Self-assembled architectures from biohybrid triblock copolymers. J. Am. Chem. Soc. 129(8), 2327-2332 (2007). (Pubitemid 46362545)
30. Doshi N, Zahra AS, Bhaskarb S, Lahannb J, Mitragotria S. Red blood cell-mimicking synthetic biomaterial particles. Proc. Natl Acad. Sci. USA 106(51), 21495-21499 2009.
31. Yake AM, Zahr AS, Jerri HA, Pishko MV, Velegol D. Localized functionalization of individual colloidal carriers for cell targeting and imaging. Biomacromolecules 8(6), 1958-1965 (2007). (Pubitemid 47009976)
32. Salem AK, Searson PC, Leong KW. Multifunctional nanorods for gene delivery. Nat. Mater. 2(10), 668-671 (2003).
33. Strømme M, Brohede U, Atluri R, Garcia- Bennett AE. Mesoporous silica-based nanomaterials for drug delivery: evaluation of structural properties associated with release rate. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1(1), 140-148 (2009).
34. Kuznetsov YG, Malkin AJ, Lucas RW, Plomp M, McPherson A. Imaging of viruses by atomic force microscopy. J. Gen. Virol. 82(9), 2025-2034 (2001). (Pubitemid 32827582)
35. Rossmann MG, Mesyanzhinov VV, Arisaka F, Leiman PG. The bacteriophage T4 DNA injection machine. Curr. Opin. Struct. Biol. 14(2), 171-180 (2004). (Pubitemid 38490783)
36. Yoo J-W, Irvine DJ, Discher DE, Mitragotri S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 10(7), 521-535 (2011).
37. Rapti K, Chaanine AH, Hajjar RJ. Targeted gene therapy for the treatment of heart failure. Can. J. Cardiol. 27(3), 265-283.
38. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9(8), 615-627 (2010).
39. Murciano J-C, Medinilla S, Eslin D, Atochina E, Cines DB, Muzykantov VR. Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes. Nat. Biotechnol. 21(8), 891-896 (2003). (Pubitemid 36936194)
40. Danielyan K, Ganguly K, Ding BS et al. Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation 118(14), 1442-1449 (2008).
41. Chambers E, Mitragotri S. Prolonged circulation of large polymeric nanoparticles by noncovalent adsorption on erythrocytes. J. Control. Release 100(1), 111-119 (2004). (Pubitemid 39451782)
42. Merkel TJ, Herlihy K. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc. Natl Acad. Sci. USA 108(2), 586-591 (2011).
43. Kazmaier NC. Bridging size scales with self assembling supramolecular materials. MRS Bull. 25, 30-30 (2000).
44. Rolland JP, Hagberg EC, Denison GM, Carter KR, De Simone JM. High-resolution soft lithography: enabling materials for nanotechnologies. Angewandte Chem. Int. Ed. 43(43), 5796-5799 (2004). (Pubitemid 39532037)
45. Canelas DA, Herlihy K, DeSimone JM. Top-down particle fabrication: control of size and shape for diagnostic imaging and drug delivery. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1(4), 391-404 (2009).
46. Truong TT, Lin R, Jeon S et al. Soft lithography using acryloxy perfluoropolyether composite stamps. Langmuir 23(5), 2898-2905 (2007). (Pubitemid 46383716)
47. Rolland JP, Maynor BW, Euliss LE, Exner AE, Denison GM, DeSimone JM. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J. Am. Chem. Soc. 127(28), 10096-10100 (2005). (Pubitemid 40995455)
48. Gratton SE, Pohlhaus PD, Lee J et al. Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT(TM) nanoparticles. J. Control. Release 121(1-2), 10-18 (2007). (Pubitemid 47126067)
49. Champion JA, Katare YK, Mitragotri S. Making polymeric micro- and nanoparticles of complex shapes. Proc. Natl Acad. Sci. USA 104(29), 11901-11904 (2007). (Pubitemid 47185602)
50. Champion JA, Katare YK, Mitragotri S. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. J. Control. Release 121(1-2), 3-9 (2007). (Pubitemid 47126059)
51. Glangchai LC, Caldorera-Moore M, Shi L, Roy K. Nanoimprint lithography based fabrication of shape-specific, enzymatically-triggered smart nanoparticles. J. Control. Release 125(3), 263-272 (2008).
52. Whitesides GM, Boncheva M. Beyond molecules: self-assembly of mesoscopic and macroscopic components. Proc. Natl Acad. Sci. USA 99(8), 4769-4774 (2002). (Pubitemid 34411449)
53. Drummond DC, Meyer O, Hong K, Kirpotin DB, Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharm. Rev. 51(4), 691-744 (1999).
54. Tao L, Zhao XM, Gao JM, Hu W, Lithographically defined uniform worm-shaped polymeric nanoparticles Nanotechnology 21(9) 095301 (2010).
55. Tao L, Crouch A, Yoon F et al. Surface energy induced patterning of organic and inorganic materials on heterogeneous Si surfaces. J. Vac. Sci. Technol. B 25(6), 1993-1997 (2007). (Pubitemid 350255824)
56. Stolnik S, Illum L, Davis SS. Long circulating microparticulate drug carriers. Adv. Drug Deliv. Rev. 16(2-3), 195-214 (1995).
57. Mitragotri S, Lahann J. Physical approaches to biomaterial design. Nat. Mater. 8(1), 15-23 (2009).
58. Huang S-D. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J. Control. Release 145(3), 178-181 (2010).
59. Devika B, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano. Lett. 6(4), 662-668. (2006).
60. Lee H, Hoang B, Reilly RM, Allen C. The effects of particle size and molecular targeting on the intratumoral and subcellular distribution of polymeric nanoparticles. Mol. Pharm. 7(4), 1195-1208 (2010).
61. Haun JB, Hammer DA. Quantifying nanoparticle adhesion mediated by specific molecular interactions. Langmuir 24(16), 8821-8832 (2008).
62. Nishiyama N. Nanomedicine: nanocarriers shape up for long life. Nat. Nanotechnol. 2, 203-204 (2007). (Pubitemid 46739817)
63. Ferrari M. Nanogeometry: beyond drug delivery. Nat. Nanotechnol. 3, 131-132 (2008). (Pubitemid 351355138)
64. Cai S, Vijayan K, Cheng D, Lima EM, Discher DE. Micelles of different morphologies - advantages of worm-like filomicelles of PEO-PCL in paclitaxel delivery pharmaceutical research. 24(11), 2099-2109 (2008).
65. Shinde Patil VR, Campbell CJ, Yun YH, Slack SM, Goetz DJ. Particle diameter influences adhesion under flow. Biophys. J. 80(4), 1733-1743 (2001). (Pubitemid 32280989)
66. Christian DA, Cai S, Garbuzenko OB et al. Flexible filaments for in vivo imaging and delivery: persistent circulation of filomicelles opens the dosage window for sustained tumor shrinkage. Mol. Pharm. 6(5), 1343-1352 (2009).
67. Muro S, Garnacho C, Champion JA et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol. Ther. 16(8), 1450-1458 (2008).
68. Decuzzi P, Ferrari M. The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 27(30), 5307-5314 (2006). (Pubitemid 44080296)
69. Decuzzi P, Lee S, Bhushan B, Ferrari M. A theoretical model for the margination of particles within blood vessels. Ann. Biomed. Eng. 33(2), 179-190 (2005). (Pubitemid 40509493)
70. Decuzzi P, Lee S, Decuzzi M, Ferrari M. Adhesion of microfabricated particles on vascular endothelium: a parametric analysis. Ann. Biomed. Eng. 32(6), 793-802 (2004).
71. Tao L, Hu W, Liu Y, Huang G, Sumer BD, Gao J. Shape-specific polymeric nanomedicine: emerging opportunities and challenges. Exp. Biol. Med. 236(1), 20-29 (2011).
72. Shah S, Liu Y, Hu W, Gao J. Modeling particle shape-dependent dynamics in nanomedicine. J. Nanosci. Nanotechnol. 11(2), 919-928 (2011).
73. Tan J, Thomas A, Liu Y. Influence of red blood cells on nanoparticle targeted delivery in microcirculation. Soft Matter doi:10.1039/ c2sm06391c (2011) (Epub ahead of print).
74. Decuzzi P, Godin B, Tanaka T et al. Size and shape effects in the biodistribution of intravascularly injected particles. J. Control. Release 141(3), 320-327 (2010).
75. Wang J, Byrne JD, Napier ME, DeSimone JM. More effective nanomedicines through particle design. Small 7(14), 1919-1931 (2011).
76. Chithrani BD, Chan WC. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 7(6), 1542-1550 (2007). (Pubitemid 47140422)
77. Yang K, Ma YQ. Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. Nat. Nano 5(8), 579-583 (2010).
78. Serda RE, Mack A, Pulikkathara M et al. Drug delivery: cellular association and assembly of a multistage delivery system. Small 6(12), 1329-1340 (2010).
79. Gratton SE, Ropp PA, Pohlhaus PD et al. The effect of particle design on cellular internalization pathways. Proc. Natl Acad. Sci. USA 105(33), 11613-11618 (2008).
80. Champion JA, Mitragotri S. Role of target geometry in phagocytosis. Proc. Natl Acad. Sci. USA 103(13), 4930-4934 (2006).
81. Lamprecht A, Ubrich N, Hombreiro Pérez M, Lehr C, Hoffman M, Maincent P. Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification. Int. J. Pharm. 184(1), 97-105 (1999). (Pubitemid 29308999)
82. Pandey R, Zahoor A, Sharma S, Khuller GK. Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis. Tuberculosis 83(6), 373-378 (2003). (Pubitemid 37464042)
83. Orive G, Hernández RM, Gascón AR, Pedraz JL. Micro and nano drug delivery systems in cancer therapy. Cancer Ther. 3, 131-128 (2005).
84. Loverde SM, Klein ML, Discher DE. Nanoparticle shape improves delivery: rational coarse grain molecular dynamics (rCG-MD) of Taxol in worm-like PEG-PCL micelles. Adv. Mat. doi: 10.1002/ adma.201103192 (2011) (Epub ahead of print).
85. He Q, Shi J. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J. Mat. Chem. 21(16), 5845-5855 (2011).
86. Torney F, Trewyn BG, Lin V, Wang K. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. Nat. Nano 2(5), 295-300 (2007). (Pubitemid 46882970)
87. Meng H, Liong M, Xia T et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 4(8), 4539-4550 (2010).
88. Martin CR, Kohli P. The emerging field of nanotube biotechnology. Nat. Rev. Drug Discov. 2(1), 29-37 (2003). (Pubitemid 37361622)
89. Arifin DY, Lee LY, Wang CH. Mathematical modeling and simulation of drug release from microspheres: implications to drug delivery systems. Adv. Drug Deliv. Rev. 58(12-13), 1274-1325 (2006).
90. Grassi M, Grassi G. Mathematical modelling and controlled drug delivery: matrix systems. Curr. Drug Deliv. 2(1), 97-116 (2005). (Pubitemid 40590925)
91. Zhu Y, Shi J, Shen W et al. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure. Angewandte Chem. Int. Ed. 44(32), 5083-5087 (2005). (Pubitemid 41199825)
92. Thomas CR, Ferris DP, Lee JH et al. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J. Am. Chem. Soc. 132(31), 10623-10625 (2010).
93. Mal NK, Fujiwara M, Tanaka Y. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature 421(6921), 350-353 (2003). (Pubitemid 36157928)
94. Zhou K, Wang Y, Huang X, Luby-Phelps K, Sumer BD, Gao J. Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells. Angewandte Chem. Int. Ed. 50(27), 6109-6114 (2011).
95. Choi S-W, Zhang Y, Xia Y. A temperature-sensitive drug release system based on phase-change materials. Angewandte Chem. 122(43), 8076-8080 (2010).
96. Wang C, Chen Q, Wang Z, Zhang X. An enzyme-responsive polymeric superamphiphile. Angewandte Chem. Int. Ed. 49(46), 8612-8615 (2010).
97. Li YL, Zhu L, Liu Z et al. Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angewandte Chem. Int. Ed. 48(52), 9914-9918 (2009).
98. Febvay S, Marini DM, Belcher AM, Clapham DE. Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated, light-triggered endosome disruption. Nano Lett. 10(6), 2211-2219 (2010).
99. Soppimath KS, Liu L-H, Seow WY et al. Multifunctional core/shell nanoparticles self-assembled from pH-induced thermosensitive polymers for targeted intracellular anticancer drug delivery. Adv. Funct. Mat. 17(3), 355-362 (2007).
100. Yang Z, Huck WT, Clarke SM, Tajbakhsh AR, Terentjev EM. Shape-memory nanoparticles from inherently non-spherical polymer colloids. Nat. Mater. 4(6), 486-490 (2005). (Pubitemid 40774054)
101. Hwang DK, Oakey J, Toner M et al. Stop-flow lithography for the production of shape-evolving degradable microgel particles. J. Am. Chem. Soc. 131(12), 4499-4504 (2009).
102. Yoo J-W, Mitragotri S. Polymer particles that switch shape in response to a stimulus. Proc. Natl Acad. Sci. USA 107(25), 11205-11210 (2010).
103. Shuvaev VV, Ilies MA, Simone E et al. Endothelial targeting of antibody-decorated polymeric filomicelles. ACS Nano 5(9), 6991-6999 (2011).
104. van den Brom CR, Anac I, Roskamp RF et al. The swelling behaviour of thermoresponsive hydrogel/silica nanoparticle composites. J. Mat. Chem. 20(23), 4827-4839 (2010).
105. Caldorera-Moore M, Kang MK, Moore Z et al. Swelling behavior of nanoscale, shape- and size-specific, hydrogel particles fabricated using imprint lithography. Soft Matter 7(6), 2879-2887 (2011).
106. Briggs JA, Grunewald K, Glass B, Förster F, Kräusslich HG, Fuller SD. The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions. Structure 14(1), 15-20 (2006). (Pubitemid 43350069)